Source: Virtual Congress 2021 – Advances in diagnosis, treatment and clinical management of nontuberculous mycobacterial disease



Rating:

Share or cite this content

Citations should be made in the following way:
R. Hull (Sheffield, United Kingdom), J. Huang (Dundee, United Kingdom), A. Dicker (Dundee, United Kingdom), H. Keir (Dundee, United Kingdom), H. Ellis (London, United Kingdom), B. Cookson (London, United Kingdom), M. Moffatt (London, United Kingdom), M. Loebinger (London, United Kingdom), J. Chalmers (Dundee, United Kingdom). Sputum proteomics of CF, BE and COPD with or without NTM infections. 3091

Member's Comments

No comment yet.

Related content which might interest you: TB, NTM and bronchiectasis Source: ERS Skills Course 2016 Year: 2016 Sputum microbiology in patients with stabile COPD Source: International Congress 2015 – Non-inflammatory monitoring of airway diseases Year: 2015 Sputum biomarkers in COPD exacerbations Source: Annual Congress 2011 - Monitoring exacerbations of airway diseases Year: 2011 Sputum galactomannan in COPD patients with and without bronchiectasis Source: International Congress 2017 – Bronchial asthma management Year: 2017 Non-tuberculous mycobacterial lung disease and COPD Source: Eur Respir Monogr 2015; 69: 172-184 Year: 2015 Lung function and bacterial pathogens in sputum of patients with acute exacerbation of COPD Source: Eur Respir J 2004; 24: Suppl. 48, 408s Year: 2004 The difference of airway microbiota between nontuberculous mycobacteria lung disease and bronchiectasis Source: Virtual Congress 2020 – New investigations of bronchiectasis and non-tuberculous mycobacteria Year: 2020 Sputum proteomics identifies distinct endotypes of exacerbations in bronchiectasis Source: Virtual Congress 2020 – Chronic lung diseases: novel methods, diagnostics and biomarkers Year: 2020 From detection of nontuberculous mycobacteria (NTM) in pulmonary specimens to pulmonary infections Source: Eur Respir J 2004; 24: Suppl. 48, 420s Year: 2004 Chronic infections, bronchiectasis and nontuberculous mycobacteria Source: ERS Course 2018 - Respiratory Infections Year: 2018 Serial sputum induction in nontuberculous mycobacterial pulmonary disease Source: Eur Respir J, 55 (6) 1902196; 10.1183/13993003.02196-2019 Year: 2020 Spontaneous sputum production as a marker of bacterial colonisation in stable COPD Source: Annual Congress 2005 - Acute and chronic infections in COPD Year: 2005 Is induced sputum more useful than expectorated sputum to identify respiratory pathogens in children with cystic fibrosis? Source: Eur Respir J 2007; 30: Suppl. 51, 31s Year: 2007 Immunometabolic markers and the sputum microbiome in bronchiectasis Source: Virtual Congress 2021 – Bronchiectasis heterogeneity: assessing the endotypes Year: 2021 Bacterial infections in COPD Source: Research Seminar 2008 - Host-pathogen interactions in the lung: implications for treatment of respiratory infections and inflammatory lung diseases Year: 2008 Bacterial pathogens in sputum and pharyngeal specimens in elderly chronic lung disease patients Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD Year: 2008 Respiratory infections associated with nontuberculous mycobacteria in non-HIV patients Source: Eur Respir J 2006; 28: 1211-1215 Year: 2006 Sputum colour as a marker of acute bacterial exacerbations of COPD Source: Annual Congress 2003 - COPD - basic mechanisms and therapy of acute exacerbations Year: 2003 Analysis of microbiological colonization in COPD patients with or without bronchiectasis Source: Virtual Congress 2020 – News on clinical evaluation of bronchiectasis, cough and inflammatory disease Year: 2020 Sputum neutrophil mediators in experimental rhinovirus infection in COPD Source: Annual Congress 2013 –Viral infections Year: 2013